Prevention and early detection of prostate cancer

J Cuzick, MA Thorat, G Andriole, OW Brawley… - The lancet …, 2014 - thelancet.com
Prostate cancer is a common malignancy in men and the worldwide burden of this disease
is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control …

MicroRNA in prostate, bladder, and kidney cancer: a systematic review

JWF Catto, A Alcaraz, AS Bjartell, RDV White… - European urology, 2011 - Elsevier
CONTEXT: MicroRNAs (miRNA) are noncoding RNAs that post-transcriptionally regulate
gene expression. Their altered expression and function have been observed in most …

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis

AW Roddam, MJ Duffy, FC Hamdy, AM Ward, J Patnick… - European urology, 2005 - Elsevier
OBJECTIVE:: Measurement of serum prostate-specific antigen (PSA) for the detection of
prostate cancer has poor specificity in men with PSA levels between 2 and 10ng/ml. It has …

[HTML][HTML] 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer

FC Hamdy, JL Donovan, JA Lane… - … England Journal of …, 2016 - Mass Medical Soc
Background The comparative effectiveness of treatments for prostate cancer that is detected
by prostate-specific antigen (PSA) testing remains uncertain. Methods We compared active …

[HTML][HTML] Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer

FC Hamdy, JL Donovan, JA Lane… - … England Journal of …, 2023 - Mass Medical Soc
Background Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and
69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer …

[HTML][HTML] Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer

JL Donovan, FC Hamdy, JA Lane… - … England Journal of …, 2016 - Mass Medical Soc
Background Robust data on patient-reported outcome measures comparing treatments for
clinically localized prostate cancer are lacking. We investigated the effects of active …

Multiple newly identified loci associated with prostate cancer susceptibility

RA Eeles, Z Kote-Jarai, GG Giles, AAA Olama, M Guy… - Nature …, 2008 - nature.com
Prostate cancer is the most common cancer affecting males in developed countries. It shows
consistent evidence of familial aggregation, but the causes of this aggregation are mostly …

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

FR Schumacher, AA Al Olama, SI Berndt, S Benlloch… - Nature …, 2018 - nature.com
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

RA Eeles, AAA Olama, S Benlloch, EJ Saunders… - Nature …, 2013 - nature.com
Prostate cancer is the most frequently diagnosed cancer in males in developed countries. To
identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a …

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng… - Nature …, 2021 - nature.com
Prostate cancer is a highly heritable disease with large disparities in incidence rates across
ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer …